Arvinas (ARVN) Preferred Dividend Payments (2017 - 2018)
Arvinas' (ARVN) quarterly Preferred Dividend Payments came in at $112.1 million in Q3 2018, up 655.36% quarter-over-quarter from $14.8 million in Q2 2018.
Arvinas (ARVN) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Arvinas' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $112.1 million for Q3 2018.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $112.1 million in Q3 2018; TTM through Sep 2019 was $112.1 million, a 44.79% decrease from a year earlier, with the FY2018 full-year figure at $198.4 million, up 4240.22% from the prior year.
- Preferred Dividend Payments grew to $112.1 million in Q3 2018 per ARVN's latest filing, from $14.8 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $112.1 million in Q3 2018 and bottomed at $4.6 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 112.05 Mn |
| Jun 30, 2018 | 14.83 Mn |
| Mar 31, 2018 | 71.48 Mn |
| Dec 31, 2017 | 4.57 Mn |